These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18312972)

  • 41. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.
    Patel RR; Christensen ME; Hodge CW; Adkison JB; Das RK
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):970-3. PubMed ID: 18313521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A dosimetric comparison of Xoft Axxent Electronic Brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial cancer.
    Dickler A; Kirk MC; Coon A; Bernard D; Zusag T; Rotmensch J; Wazer DE
    Brachytherapy; 2008; 7(4):351-4. PubMed ID: 18783991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. External beam radiotherapy and high dose rate brachytherapy for medically unfit and elderly patients.
    Marijnen CA
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):706-10. PubMed ID: 17826039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Measurement of source strength for 192Ir HDR RALS].
    Abe Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Dec; 62(12):1592-7. PubMed ID: 17233119
    [No Abstract]   [Full Text] [Related]  

  • 45. [Dose-effect measurements as a basis for computer-assisted dose distribution planning in brachytherapy].
    Fichte B; Schumann E
    Strahlentherapie; 1984 May; 160(5):324-7. PubMed ID: 6729867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Size and positioning reproducibility of an 192Ir brachytherapy stepping source.
    Berndt A; Rickey DW; Rathee S; Bews J
    Med Phys; 2000 Jan; 27(1):129-31. PubMed ID: 10659747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose rate in brachytherapy using after-loading machine: pulsed or high-dose rate?
    Hannoun-Lévi JM; Peiffert D
    Cancer Radiother; 2014 Oct; 18(5-6):437-40. PubMed ID: 25195117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.
    Hedman M; Bjork-Eriksson T; Mercke C; West C; Hesselius P; Brodin O
    Acta Oncol; 2009; 48(4):584-90. PubMed ID: 19107620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
    Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
    Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Variability of a dose in external irradiation by a split field].
    Tacev T; Krystof V
    Cesk Radiol; 1980 May; 34(3):186-90. PubMed ID: 6772318
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of tracheobronchial tumors with endoluminal irradiation with iridium 192 (afterloading technic)].
    Huber RM; Rohloff R; Duft S; Pforte A; Häussinger K; Mayr B; Rübe C; Haimerl W
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():357-9. PubMed ID: 3174591
    [No Abstract]   [Full Text] [Related]  

  • 52. Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169.
    Granero D; Pérez-Calatayud J; Ballester F; Bos AJ; Venselaar J
    Radiat Prot Dosimetry; 2006; 118(1):11-5. PubMed ID: 16030058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Problems of dosage and fractionation in 192iridium-afterloading radiotherapy in gynaecological cancer.
    Behrendt W
    Sonderb Strahlenther Onkol; 1988; 82():213-4. PubMed ID: 3393990
    [No Abstract]   [Full Text] [Related]  

  • 54. Fluorescent screen for high-dose-rate (HDR) brachytherapy quality assurance.
    Lightstone AW
    Med Dosim; 2005; 30(3):143-4. PubMed ID: 16112464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraluminal low-dose rate brachytherapy for malignant endobronchial obstruction.
    Lo TC; Beamis JF; Weinstein RS; Costey GE; Andrews CF; Webb-Johnson DC; Girshovich L; Leibenhaut MH
    Radiother Oncol; 1992 Jan; 23(1):16-20. PubMed ID: 1736327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In regards to Conill et al.: Brachytherapy with 192Ir as treatment of carcinoma of the tarsal structure of the eyelid (Int J Radiat Oncol Bio Phys 2004;59:1326-1329).
    Muqit MM; Roberts F
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):959. PubMed ID: 16751086
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
    de Crevoisier R; Slimane K; Sanfilippo N; Bossi A; Albano M; Dumas I; Wibault P; Fizazi K; Gerbaulet A; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1150-6. PubMed ID: 19395183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency.
    Nag S; Dally M; de la Torre M; Tatsuzaki H; Kizilbash N; Kurusun S; Pinillos L; Pokrajac B; Sur R; Levin V
    Radiother Oncol; 2002 Sep; 64(3):297-308. PubMed ID: 12242118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A method to avoid misadministrations in high dose rate brachytherapy.
    Alecu R; Feldmeier JJ; Court WS; Alecu M; Orton CG
    Med Phys; 1997 Feb; 24(2):259-61. PubMed ID: 9048366
    [No Abstract]   [Full Text] [Related]  

  • 60. [Radiobiology in brachytherapy].
    Hennequin C; Mazeron JJ
    Cancer Radiother; 2013 Apr; 17(2):81-4. PubMed ID: 23562380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.